HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wenjie He Selected Research
Wenjie He Research Topics
Disease
4
Wounds and Injuries (Trauma)
02/2024 - 01/2022
3
Neoplasms (Cancer)
01/2024 - 01/2016
2
Bites and Stings (Sting)
02/2024 - 01/2024
2
Infections
01/2024 - 12/2023
2
Ulcer
01/2023 - 01/2022
2
Neoplasm Metastasis (Metastasis)
01/2017 - 01/2016
2
Inflammation (Inflammations)
05/2012 - 01/2011
2
Bone Resorption
05/2012 - 01/2011
1
Retinoblastoma (Glioblastoma, Retinal)
02/2024
1
Colitis
12/2023
1
Necrosis
12/2023
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023
1
Diabetic Foot
01/2023
1
Fibrosis (Cirrhosis)
01/2022
1
Cerebral Palsy (Spastic Diplegia)
01/2022
1
Dizziness (Lightheadedness)
01/2022
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2022
1
Erythema
01/2022
1
Headache (Headaches)
01/2022
1
Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2022
1
COVID-19
01/2021
1
Anorexia
11/2020
1
Adenocarcinoma
10/2019
1
Breast Neoplasms (Breast Cancer)
01/2017
1
Circulating Neoplastic Cells
01/2016
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016
1
Lung Neoplasms (Lung Cancer)
01/2016
1
Multiple Myeloma
09/2013
1
Bone Diseases (Bone Disease)
09/2013
1
Osteolysis
05/2012
1
Prosthesis Failure
05/2012
1
Osteoporosis
01/2011
1
Spontaneous Abortion (Miscarriage)
09/2007
1
Placental Insufficiency
09/2007
Drug/Important Bio-Agent (IBA)
2
Antioxidants
IBA
01/2024 - 12/2023
2
Enzymes
IBA
12/2023 - 01/2017
2
Proteins (Proteins, Gene)
FDA Link
12/2023 - 01/2022
2
Cytokines
IBA
01/2022 - 01/2016
2
Purinergic P1 Receptors (Adenosine Receptor)
IBA
09/2013 - 01/2011
2
Adenosine (Adenocard)
FDA Link
Generic
09/2013 - 01/2011
1
NF-kappa B (NF-kB)
IBA
02/2024
1
Antidepressive Agents (Antidepressants)
IBA
01/2024
1
asiaticoside
IBA
01/2024
1
Anti-Anxiety Agents (Anxiolytics)
IBA
01/2024
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2024
1
Anti-Allergic Agents (Antiallergic Agents)
IBA
01/2024
1
Metals
IBA
01/2024
1
Interferons
IBA
01/2024
1
cyclic guanosine monophosphate-adenosine monophosphate
IBA
01/2024
1
Nanogels
IBA
12/2023
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
12/2023
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
12/2023
1
Dextrans (Dextran)
FDA Link
12/2023
1
Sodium
IBA
12/2023
1
Dextran Sulfate
IBA
12/2023
1
Interleukin-17 (Interleukin 17)
IBA
12/2023
1
Substance P
IBA
01/2023
1
Neuropeptides
IBA
01/2023
1
Glucose (Dextrose)
FDA Link
Generic
01/2022
1
Chemokines
IBA
01/2022
1
Inflammasomes
IBA
01/2022
1
COVID-19 Vaccines
IBA
01/2021
1
Vaccines
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
10/2019
1
Small Interfering RNA (siRNA)
IBA
01/2016
1
ErbB Receptors (EGF Receptor)
IBA
01/2016
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
01/2016
1
Tyrosine Kinase Inhibitors
IBA
01/2016
1
Carcinogens
IBA
01/2016
1
Interleukin-8 (Interleukin 8)
IBA
01/2016
1
Adenosine A2A Receptor (Adenosine A2A Receptors)
IBA
05/2012
1
Osteopontin
IBA
05/2012
1
Cathepsin K
IBA
05/2012
1
2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosine
IBA
05/2012
1
RANK Ligand
IBA
05/2012
1
Arsenic
IBA
09/2007
Therapy/Procedure
1
Surgical Amputation (Amputations)
01/2022
1
Transcranial Direct Current Stimulation
01/2022
1
Massage (Zone Therapy)
11/2020
1
Reoperation
05/2012
1
Aftercare (After-Treatment)
05/2012
1
Therapeutics
01/2011